EVRAN SEDAT 4
4 · BIO-RAD LABORATORIES, INC. · Filed Oct 22, 2024
Insider Transaction Report
Form 4
BIO-RAD LABORATORIES, INC.BIO BIOB
EVRAN SEDAT
EVP, Global Supply Chain
Transactions
- Tax Payment
Bio-Rad A Common Stock
2024-10-20$346.37/sh−335$116,034→ 853.14 total - Exercise/Conversion
Restricted Stock Units
2024-10-20−1,044→ 3,132 totalExercise: $0.00→ Bio-Rad A Common Stock (1,044 underlying) - Exercise/Conversion
Bio-Rad A Common Stock
2024-10-20+1,044→ 1,188.14 total
Footnotes (4)
- [F1]Shares of Class A common stock acquired on the vesting of restricted stock units.
- [F2]Includes 49.0480, 41.3870 and 33.7050 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 12/31/2023, 03/31/2024 and 06/30/2024, respectively.
- [F3]Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
- [F4]On October 20, 2023, the reporting person was granted 4,176 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.